Analysis of the repressor element-1 silencing transcription factorneuron-restrictive silencer factor occupancy of non-neuronal genes in peripheral lymphocytes from patients with huntington's disease

Brain Pathology

Volumn 20, Issue 1, 2010, Pages 96-105

  Marullo, Manuela ^a   Valenza, Marta ^a   Mariotti, Caterina ^b   Di Donato, Stefano ^b   Cattaneo, Elena ^a   Zuccato, Chiara ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Huntington; Lymphocytes; RESTNRSF

Indexed keywords

REPRESSOR ELEMENT 1 NEURON RESTRICTIVE SILENCER ELEMENT; REPRESSOR ELEMENT 1 SILENCING TRANSCRIPTION FACTOR NEURON RESTRICTIVE SILENCER FACTOR; REPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOFLUOROMETRY; FEMALE; GENE CONTROL; GENE TARGETING; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; IN VIVO STUDY; MALE; MONOCYTE; PERIPHERAL LYMPHOCYTE; PROTEIN BINDING; PROTEIN TARGETING; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION REGULATION;

ADULT; AGED; AGED, 80 AND OVER; CELL SEPARATION; CELLS, CULTURED; CHROMATIN; COMPUTER SIMULATION; DISEASE PROGRESSION; FEMALE; HUMANS; HUNTINGTON DISEASE; IMMUNOPRECIPITATION; LYMPHOCYTES; MALE; MIDDLE AGED; MONOCYTES; PROTEIN ARRAY ANALYSIS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 71549114589     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2008.00249.x     Document Type: Article

References (21)

1. Arm JP, Nwankwo C, Austen KF (1997) Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49b1 inhibitory receptor. J Immunol 159 : 2342 2349.
2. Belyaev ND, Wood IC, Bruce AW, Street M, Trinh JB, Buckley NJ (2004) Distinct RE-1 silencing transcription factor-containing complexes interact with different target genes. J Biol Chem 279 : 556 561.
3. Borges L, Hsu M-L, Fanger N, Kubin M, Cosman D (1997) A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol 159 : 5192 5196.
4. Borovecki F, Lovrecic L, Zhou J, Jeong H, Then F, Rosas HD et al (2005) Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc Natl Acad Sci USA 102 : 11023 11028.
5. Bruce AW, Donaldson IJ, Wood IC, Yerbury SA, Sadowski MI, Chapman M et al (2004) Genome-wide analysis of repressor element 1 silencing transcription factorneuron-restrictive silencing factor (RESTNRSF) target genes. Proc Natl Acad Sci USA 101 : 10458 10463.
6. Cattaneo E, Zuccato C, Tartari M (2005) Normal huntingtin function: an alternative approach to Huntington's disease. Nat Rev Neurosci 6 : 919 930.
7. Cella M, Dohring C, Samaridis J, Dessing M, Brockhaus M, Lanzavecchia A, Colonna M (1997) A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med 185 : 1743 1751.
8. Cha JH (2007) Transcriptional signatures in Huntington's disease. Prog Neurobiol 83 : 228 248.
9. Chang CC, Ciubotariu R, Manavalan JS, Yuan J, Colovai AI, Piazza F et al (2002) Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 3 : 237 243.
10. Chen-Plotkin AS, Sadri-Vakili G, Yohrling GJ, Braveman MW, Benn CL, Glajch KE et al (2006) Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease. Neurobiol Dis 22 : 233 241.
11. Johnson R, Gamblin RJ, Ooi L, Bruce AW, Donaldson IJ, Westhead DR et al (2006) Identification of the REST regulon reveals extensive transposable element-mediated binding site duplication. Nucleic Acids Res 34 : 3862 3877.
12. Mattei MG, Fumoux F, Roeckel N, Fougereau M, Schiff C (1991) The human pre-B-specific lambda-like cluster is located in the 22q11.2-22q12.3 region, distal to the IgC lambda locus. Genomics 9 : 544 546.
13. Pfaffl MW (2001) A new mathematical model from qualification in real time RT-PCR. Nucleic Acids Res 29 : e45.
14. Pillai S, Baltimore D (1988) The omega and iota surrogate immunoglobulin light chains. Curr Top Microbiol Immunol 137 : 136 139.
15. Reiner A, Albin RL, Anderson KD, D'Amato CJ, Penney JB, Young AB (1998) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci 85 : 5733 5737.
16. Runne H, Kuhn A, Wild EJ, Pratyaksha W, Kristiansen M, Isaacs JD et al (2007) Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood. Proc Natl Acad Sci USA 104 : 14424 14429.
17. Schiff C, Milili M, Fougereau M. (1989) Isolation of early immunoglobulin lambda-like gene transcripts in human fetal liver. Eur J Immunol 19 : 1873 1878.
18. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 : 971 983.
19. Wood IC, Belyaev ND, Bruce AW, Jones C, Mistry M, Roopra A, Buckley NJ (2003) Interaction of the repressor element 1-silencing transcription factor (REST) with target genes. J Mol Biol 334 : 863 874.
20. Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L et al (2003) Huntingtin interacts with RESTNRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 35 : 76 83.
21. Zuccato C, Belyaev N, Conforti P, Ooi L, Tartari M, Papadimou E et al (2007) Widespread disruption of repressor element-1 silencing transcription factorneuron-restrictive silencer factor occupancy at its target genes in Huntington's disease. J Neurosci 27 : 6972 6983.